ATE424812T1 - Zusammensetzung zur maskierung des geschmacks - Google Patents

Zusammensetzung zur maskierung des geschmacks

Info

Publication number
ATE424812T1
ATE424812T1 AT02763407T AT02763407T ATE424812T1 AT E424812 T1 ATE424812 T1 AT E424812T1 AT 02763407 T AT02763407 T AT 02763407T AT 02763407 T AT02763407 T AT 02763407T AT E424812 T1 ATE424812 T1 AT E424812T1
Authority
AT
Austria
Prior art keywords
composition
taste masking
carbomer
medicament
bitter taste
Prior art date
Application number
AT02763407T
Other languages
English (en)
Inventor
Michael Corbo
John Migton
Mahesh Patell
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE424812T1 publication Critical patent/ATE424812T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02763407T 2001-08-01 2002-08-01 Zusammensetzung zur maskierung des geschmacks ATE424812T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30928501P 2001-08-01 2001-08-01

Publications (1)

Publication Number Publication Date
ATE424812T1 true ATE424812T1 (de) 2009-03-15

Family

ID=23197540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02763407T ATE424812T1 (de) 2001-08-01 2002-08-01 Zusammensetzung zur maskierung des geschmacks

Country Status (11)

Country Link
US (2) US20030039687A1 (de)
EP (1) EP1411899B1 (de)
JP (1) JP2004537566A (de)
AT (1) ATE424812T1 (de)
AU (1) AU2002327418A1 (de)
CA (1) CA2457100A1 (de)
DE (1) DE60231510D1 (de)
DK (1) DK1411899T3 (de)
ES (1) ES2323264T3 (de)
PT (1) PT1411899E (de)
WO (1) WO2003011227A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060105008A1 (en) * 2002-03-28 2006-05-18 Nawaz Ahmad Compositions and methods for reducing vaginal pH
ITMI20032523A1 (it) * 2003-12-19 2005-06-20 Acraf Forma di dosaggio per uso orale comprendente un farmaco
AU2006209263A1 (en) * 2005-09-12 2007-03-29 Mcneil-Ppc, Inc. Anhydrous composition containing an acid-acid buffer system
EP1928268A1 (de) * 2005-09-30 2008-06-11 DSMIP Assets B.V. Neue polyphenolhaltige zusammensetzungen
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
ES2694710T3 (es) 2009-04-17 2018-12-26 Hexal Ag Comprimidos que comprenden un agente que enmascara el sabor
EP2437730A4 (de) * 2009-05-20 2014-02-26 Lingual Consegna Pty Ltd Orale und/oder sublinguale therapeutische formulierung
WO2010141889A1 (en) * 2009-06-05 2010-12-09 Biogenic Innovations, Llc Use of methylsulfonylmethane as a taste masking agent
JP5821247B2 (ja) * 2010-04-07 2015-11-24 大正製薬株式会社 イブプロフェンの昇華抑制方法
PT2833880T (pt) * 2012-04-02 2017-12-06 Pharma Seeds Create Llc Composição de dosagem oral sólida de ibuprofeno compreendendo um copolímero de ácido metacrílico
JP2014227406A (ja) * 2013-05-27 2014-12-08 株式会社ウメケン 苦味生薬含有粒状物
AU2022215028A1 (en) 2021-01-28 2023-06-29 Galvita Ag Solid pharmaceutical compositions and methods of producing the same
EP4311543A1 (de) 2022-07-27 2024-01-31 Galvita AG Verfahren zum laden von invertierten vorlagenträgern

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3346449A (en) * 1963-09-27 1967-10-10 Hoffmann La Roche d-methorphan compositions and methods of making same
US3857939A (en) * 1971-08-18 1974-12-31 Hoffmann La Roche Chewable sodium-free vitamin c tablets
JPS5416860B2 (de) * 1974-04-03 1979-06-26
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4649043A (en) * 1982-03-22 1987-03-10 Alza Corporation Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US5272139A (en) * 1986-08-27 1993-12-21 Cary George R Jr Amelioration or elimination of postoperative pain
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4902514A (en) * 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
CA2063141C (en) * 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
US5027997A (en) * 1990-04-05 1991-07-02 Hughes Aircraft Company Silicon chip metallization system
DK0524180T3 (da) * 1990-04-11 1995-09-04 Upjohn Co Smagsmaskering af ibuprofen ved fluid bedovertrækning
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
DE4034115C1 (de) * 1990-10-26 1992-04-02 Bayer Ag, 5090 Leverkusen, De
JP2948317B2 (ja) * 1991-05-28 1999-09-13 マクニール―ピーピーシー・インコーポレーテツド 噛める薬物投与用組成物
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
TW271400B (de) * 1992-07-30 1996-03-01 Pfizer
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US5919489A (en) * 1995-11-01 1999-07-06 Abbott Laboratories Process for aqueous granulation of clarithromycin
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
IN186245B (de) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
HN1999000174A (es) * 1998-10-30 1999-10-13 Bayer Ag Formulacion medicamentosa acuisa para administracion oral.
IN191482B (de) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
US6794411B1 (en) * 1999-04-06 2004-09-21 Laboratoire Des Produits Ethiques Ethypharm Drinkable ibuprofen pharmaceutical suspension
FR2791889B1 (fr) * 2000-04-05 2005-09-16 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable d'ibuprofene
ATE248588T1 (de) * 1999-06-11 2003-09-15 Ranbaxy Lab Ltd Geschmacksmaskierte zubereitungen
US6204270B1 (en) * 1999-11-12 2001-03-20 Eyal S. Ron Ophthalmic and mucosal preparations
IT1315274B1 (it) * 1999-12-29 2003-02-03 Cip Ninety Two 92 Sa Composizioni farmaceutiche per la somministrazione localizzata nelcavo orale di farmaci antiinfiammatori non stereoidei utili per la
US6284235B1 (en) * 2000-02-11 2001-09-04 National Starch And Chemical Company Investment Holding Corporation Bioadhesive composition
US20030017133A1 (en) * 2001-06-15 2003-01-23 Wyeth (Formerly American Home Products Corporation) Mucoadhesive composition

Also Published As

Publication number Publication date
JP2004537566A (ja) 2004-12-16
DE60231510D1 (de) 2009-04-23
EP1411899A2 (de) 2004-04-28
EP1411899A4 (de) 2006-06-07
ES2323264T3 (es) 2009-07-10
PT1411899E (pt) 2009-04-24
US20070122475A1 (en) 2007-05-31
DK1411899T3 (da) 2009-06-02
WO2003011227A2 (en) 2003-02-13
AU2002327418A1 (en) 2003-02-17
CA2457100A1 (en) 2003-02-13
US20030039687A1 (en) 2003-02-27
WO2003011227A3 (en) 2003-07-10
EP1411899B1 (de) 2009-03-11

Similar Documents

Publication Publication Date Title
DE60231510D1 (de) Zusammensetzung zur maskierung des geschmacks
MY129406A (en) Taste masked liquid pharmaceutical compositions
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
DK0776202T3 (da) Liposomalt indkapslet taxol, dets fremstilling af dets anvendelse
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
NZ515392A (en) Respiratory syncytial virus replication inhibitors
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
ECSP088577A (es) Enmascaramiento del sabor de polvos
GB2363985B (en) Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
ATE546151T1 (de) Verwendung von hcg-fragmente enthaltene zusammensetzungen zur mukosalen und oralen anwendung
IL160523A0 (en) PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
BR0213379A (pt) Formulação resistente a derramamento de mascaramento de gosto
ECSP034795A (es) "composiciones que contienen imidazotriazinona para administración nasal"
ATE404212T1 (de) Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung
WO2001076601A3 (en) Pharmaceutical compositions comprising salmeterol and ipratropium
PL369296A1 (en) Use of gp130 activators in diabetic neuropathy
MXPA04001912A (es) Aminobenzofenonas novedosas.
ATE399543T1 (de) Neue synergistische zusammensetzung enthaltend roflumilast und formoterol
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
EA200700979A1 (ru) Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола
ATE332693T1 (de) Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose
ATE452639T1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
DE60202299D1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1411899

Country of ref document: EP

REN Ceased due to non-payment of the annual fee